Effect / research focus
Distinguished online from the DAC version and discussed for growth-hormone signalling; approval and confirmed safety are lacking.
Back to the peptide atlas
Endocrine signalsPeptideNot FDA/EMA approved
CJC-1295 no DAC
Shorter-acting GHRH analogue without the drug-affinity complex
Also known as: CJC-1295 without DAC · Modified GRF 1-29 · Mod GRF
How communities discuss it
Discussed in online communities in relation to the research focus described above. Anecdotes are not evidence of efficacy and are not use instructions.
Community reports are anecdotes, not evidence of efficacy or safety.
Why there is no mixing guide here
Reconstitution depends on the exact approved product, its official label and medical supervision. With unapproved substances, identity, concentration, sterility and stability are often unknown. A universal step-by-step guide would therefore be unsafe.
Primary sources
The linked regulator and trial-register sources support the current status summary.